Advertisement

Neurodevelopmental Outcomes

  • Katherine Lord
  • Diva D. De León-CrutchlowEmail author
Chapter
Part of the Contemporary Endocrinology book series (COE)

Abstract

Infants and children with hyperinsulinism are at high risk of brain damage. Multiple studies have demonstrated the increased prevalence of both neurodevelopmental abnormalities (26–48%) and seizures (13–29%) in the hyperinsulinism population. Individuals are at risk of poor neurodevelopmental outcomes regardless of the duration of the hyperinsulinism or treatment modality. All children with hyperinsulinism require screening for developmental issues and swift intervention if abnormalities are identified.

Keywords

Hyperinsulinism Hypoglycemia Developmental delay Seizures 

References

  1. 1.
    Avatapalle HB, Banerjee I, Shah S, et al. Abnormal neurodevelopmental outcomes are common in children with transient congenital hyperinsulinism. Front Endocrinol. 2013;4:60.CrossRefGoogle Scholar
  2. 2.
    Vannucci RC, Vannucci SJ. Hypoglycemic brain injury. Semin Neonatol: SN. 2001;6(2):147–55.CrossRefGoogle Scholar
  3. 3.
    Weng JT, Nakamura Y, Spitzer JJ. Arterial concentration and cerebral removal of metabolites in fasting puppies. Am J Phys. 1973;225(4):967–71.Google Scholar
  4. 4.
    Arbelaez AM, Semenkovich K, Hershey T. Glycemic extremes in youth with T1DM: the structural and functional integrity of the developing brain. Pediatr Diabetes. 2013;14(8):541–53.CrossRefGoogle Scholar
  5. 5.
    Northam EA, Rankins D, Lin A, et al. Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care. 2009;32(3):445–50.CrossRefGoogle Scholar
  6. 6.
    Anderson JM, Milner RD, Strich SJ. Effects of neonatal hypoglycaemia on the nervous system: a pathological study. J Neurol Neurosurg Psychiatry. 1967;30(4):295–310.CrossRefGoogle Scholar
  7. 7.
    Larroche JC. Developmental pathology of the neonate. Amsterdam: Excerpta Medica; 1977.Google Scholar
  8. 8.
    Burns CM, Rutherford MA, Boardman JP, Cowan FM. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics. 2008;122(1):65–74.CrossRefGoogle Scholar
  9. 9.
    Boardman JP, Hawdon JM. Hypoglycaemia and hypoxic-ischaemic encephalopathy. Dev Med Child Neurol. 2015;57(Suppl 3):29–33.CrossRefGoogle Scholar
  10. 10.
    Harken AH, Filler RM, AvRuskin TW, Crigler JF Jr. The role of “total” pancreatectomy in the treatment of unremitting hypoglycemia of infancy. J Pediatr Surg. 1971;6(3):284–9.CrossRefGoogle Scholar
  11. 11.
    Thomas CG Jr, Underwood LE, Carney CN, Dolcourt JL, Whitt JJ. Neonatal and infantile hypoglycemia due to insulin excess: new aspects of diagnosis and surgical management. Ann Surg. 1977;185(5):505–17.CrossRefGoogle Scholar
  12. 12.
    Menni F, de Lonlay P, Sevin C, et al. Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics. 2001;107(3):476–9.CrossRefGoogle Scholar
  13. 13.
    Steinkrauss L, Lipman TH, Hendell CD, Gerdes M, Thornton PS, Stanley CA. Effects of hypoglycemia on developmental outcome in children with congenital hyperinsulinism. J Pediatr Nurs. 2005;20(2):109–18.CrossRefGoogle Scholar
  14. 14.
    Meissner T, Wendel U, Burgard P, Schaetzle S, Mayatepek E. Long-term follow-up of 114 patients with congenital hyperinsulinism. Eur J Endocrinol. 2003;149(1):43–51.CrossRefGoogle Scholar
  15. 15.
    Ludwig A, Enke S, Heindorf J, Empting S, Meissner T, Mohnike K. Formal neurocognitive testing in 60 patients with congenital hyperinsulinism. Horm Res Paediatr. 2017.Google Scholar
  16. 16.
    Lord K, Radcliffe J, Gallagher PR, Adzick NS, Stanley CA, De Leon DD. High risk of diabetes and neurobehavioral deficits in individuals with surgically treated hyperinsulinism. J Clin Endocrinol Metab. 2015;100(11):4133–9.CrossRefGoogle Scholar
  17. 17.
    Bahi-Buisson N, Roze E, Dionisi C, et al. Neurological aspects of hyperinsulinism-hyperammonaemia syndrome. Dev Med Child Neurol. 2008;50(12):945–9.CrossRefGoogle Scholar
  18. 18.
    Helleskov A, Melikyan M, Globa E, et al. Both low blood glucose and insufficient treatment confer risk of neurodevelopmental impairment in congenital hyperinsulinism: a multinational cohort study. Front Endocrinol. 2017;8:156.CrossRefGoogle Scholar
  19. 19.
    Jack MM, Greer RM, Thomsett MJ, et al. The outcome in Australian children with hyperinsulinism of infancy: early extensive surgery in severe cases lowers risk of diabetes. Clin Endocrinol. 2003;58(3):355–64.CrossRefGoogle Scholar
  20. 20.
    Boyle CA, Boulet S, Schieve LA, et al. Trends in the prevalence of developmental disabilities in US children, 1997–2008. Pediatrics. 2011;127(6):1034–42.CrossRefGoogle Scholar
  21. 21.
    Black LI, Vahratian A, Hoffman HJ. Communication disorders and use of intervention services among children aged 3–17 years: United States, 2012. NCHS Data Brief. 2015;(205):1–8.Google Scholar
  22. 22.
    Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 2015;56(3):345–65.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Division of Endocrinology and Diabetes, Department of PediatricsPerelman School of Medicine at the University of Pennsylvania and The Children’s Hospital of PhiladelphiaPhiladelphiaUSA

Personalised recommendations